EPH247 Pain and Arthralgia Adverse Events Associated with Crizanlizumab and Voxelotor: Disproportionality Analysis of US FDA Adverse Events Reporting System (FAERS)
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.2593
https://www.valueinhealthjournal.com/article/S1098-3015(23)02783-3/fulltext
Section Title :
Section Order :
10566
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02783-3&doi=10.1016/j.jval.2023.03.2593